# cPSTA System CADLAD Study

Study · id `cardio:ct-nct02784197` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02784197](<https://clinicaltrials.gov/study/NCT02784197>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02784197

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2622 participants.

## Technical summary

Registry record NCT02784197. Allocation not applicable; no masking; primary purpose diagnostic. Start 2016-05 (actual); primary completion 2017-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 2622 participants (enrolled count; ClinicalTrials.gov record NCT02784197, source copy `cardio:ctgov-nct02784197-2019-06-12`, retrieved 2026-10-26)
- Started: 2016-05 (actual) (ClinicalTrials.gov record NCT02784197, source copy `cardio:ctgov-nct02784197-2019-06-12`, retrieved 2026-10-26)
- Primary completion: 2017-12 (actual) (ClinicalTrials.gov record NCT02784197, source copy `cardio:ctgov-nct02784197-2019-06-12`, retrieved 2026-10-26)
- Completion: 2018-05 (actual) (ClinicalTrials.gov record NCT02784197, source copy `cardio:ctgov-nct02784197-2019-06-12`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02784197-2019-06-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: cPSTA System CADLAD Study
- Acronym: CADLAD
- Condition: Coronary Artery Disease
- Intervention (Device): Phase Signal Recorder
- Lead sponsor: Analytics For Life
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Analytics For Life (`cardio:org-analytics-for-life`)

## Provenance

Content hash: ecb4a00cd2b90575cffd22d2555d94e3189ffd1a29c09b47cd390299d2700569
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
